365 related articles for article (PubMed ID: 25413946)
1. The Intracellular Domain of Amyloid Precursor Protein is a Potential Therapeutic Target in Alzheimer's Disease.
Nagase H; Nakayama K
Curr Drug Discov Technol; 2014; 11(4):243-58. PubMed ID: 25413946
[TBL] [Abstract][Full Text] [Related]
2. γ-Secretase-regulated mechanisms similar to notch signaling may play a role in signaling events, including APP signaling, which leads to Alzheimer's disease.
Nakayama K; Nagase H; Koh CS; Ohkawara T
Cell Mol Neurobiol; 2011 Aug; 31(6):887-900. PubMed ID: 21516353
[TBL] [Abstract][Full Text] [Related]
3. γ-Secretase-regulated signaling typified by Notch signaling in the immune system.
Nagase H; Nakayama K
Curr Stem Cell Res Ther; 2013 Sep; 8(5):341-56. PubMed ID: 23957936
[TBL] [Abstract][Full Text] [Related]
4. Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein.
Yang T; Arslanova D; Gu Y; Augelli-Szafran C; Xia W
Mol Brain; 2008 Nov; 1():15. PubMed ID: 18983676
[TBL] [Abstract][Full Text] [Related]
5. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
6. AICD nuclear signaling and its possible contribution to Alzheimer's disease.
Konietzko U
Curr Alzheimer Res; 2012 Feb; 9(2):200-16. PubMed ID: 21605035
[TBL] [Abstract][Full Text] [Related]
7. Activity of gamma-secretase on substrates other than APP.
Lleó A
Curr Top Med Chem; 2008; 8(1):9-16. PubMed ID: 18220928
[TBL] [Abstract][Full Text] [Related]
8. Intracellular pH regulates amyloid precursor protein intracellular domain accumulation.
Vingtdeux V; Hamdane M; Bégard S; Loyens A; Delacourte A; Beauvillain JC; Buée L; Marambaud P; Sergeant N
Neurobiol Dis; 2007 Mar; 25(3):686-96. PubMed ID: 17207630
[TBL] [Abstract][Full Text] [Related]
9. Similar mechanisms regulated by gamma-secretase are involved in both directions of the bi-directional Notch-Delta signaling pathway as well as play a potential role in signaling events involving type 1 transmembrane proteins.
Nakayama K; Nagase H; Hiratochi M; Koh CS; Ohkawara T
Curr Stem Cell Res Ther; 2008 Dec; 3(4):288-302. PubMed ID: 19075758
[TBL] [Abstract][Full Text] [Related]
10. γ-Secretase in Alzheimer's disease.
Hur JY
Exp Mol Med; 2022 Apr; 54(4):433-446. PubMed ID: 35396575
[TBL] [Abstract][Full Text] [Related]
11. The novel gamma secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) reduces amyloid plaque deposition without evidence of notch-related pathology in the Tg2576 mouse.
Best JD; Smith DW; Reilly MA; O'Donnell R; Lewis HD; Ellis S; Wilkie N; Rosahl TW; Laroque PA; Boussiquet-Leroux C; Churcher I; Atack JR; Harrison T; Shearman MS
J Pharmacol Exp Ther; 2007 Feb; 320(2):552-8. PubMed ID: 17099072
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway.
Liao YF; Wang BJ; Cheng HT; Kuo LH; Wolfe MS
J Biol Chem; 2004 Nov; 279(47):49523-32. PubMed ID: 15347683
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD production.
Dimitrov M; Alattia JR; Lemmin T; Lehal R; Fligier A; Houacine J; Hussain I; Radtke F; Dal Peraro M; Beher D; Fraering PC
Nat Commun; 2013; 4():2246. PubMed ID: 23907250
[TBL] [Abstract][Full Text] [Related]
14. Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease.
Bandyopadhyay S; Goldstein LE; Lahiri DK; Rogers JT
Curr Med Chem; 2007; 14(27):2848-64. PubMed ID: 18045131
[TBL] [Abstract][Full Text] [Related]
15. Increased Foxo3a Nuclear Translocation and Activity is an Early Neuronal Response to βγ-Secretase-Mediated Processing of the Amyloid-β Protein Precursor: Utility of an AβPP-GAL4 Reporter Assay.
Law BM; Guest AL; Pullen MWJ; Perkinton MS; Williams RJ
J Alzheimers Dis; 2018; 61(2):673-688. PubMed ID: 29254083
[TBL] [Abstract][Full Text] [Related]
16. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.
D'Onofrio G; Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Paroni G; Cascavilla L; Seripa D; Pilotto A
Expert Opin Drug Discov; 2012 Jan; 7(1):19-37. PubMed ID: 22468891
[TBL] [Abstract][Full Text] [Related]
17. The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase.
Nunan J; Shearman MS; Checler F; Cappai R; Evin G; Beyreuther K; Masters CL; Small DH
Eur J Biochem; 2001 Oct; 268(20):5329-36. PubMed ID: 11606195
[TBL] [Abstract][Full Text] [Related]
18. Alpha-secretase cleavage of the amyloid precursor protein: proteolysis regulated by signaling pathways and protein trafficking.
Lichtenthaler SF
Curr Alzheimer Res; 2012 Feb; 9(2):165-77. PubMed ID: 21605033
[TBL] [Abstract][Full Text] [Related]
19. Catalytic site-directed gamma-secretase complex inhibitors do not discriminate pharmacologically between Notch S3 and beta-APP cleavages.
Lewis HD; Pérez Revuelta BI; Nadin A; Neduvelil JG; Harrison T; Pollack SJ; Shearman MS
Biochemistry; 2003 Jun; 42(24):7580-6. PubMed ID: 12809514
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen Sulfide Selectively Inhibits γ-Secretase Activity and Decreases Mitochondrial Aβ Production in Neurons from APP/PS1 Transgenic Mice.
Zhao FL; Qiao PF; Yan N; Gao D; Liu MJ; Yan Y
Neurochem Res; 2016 May; 41(5):1145-59. PubMed ID: 26708452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
